J&J: To License Novel Oral Assets, Further Strengthening Commitment to Atopic Dermatitis
強生:授權新型口服資產,進一步加強對特應性皮炎的承諾
J&J: To License Novel Oral Assets, Further Strengthening Commitment to Atopic Dermatitis
強生:授權新型口服資產,進一步加強對特應性皮炎的承諾
使用瀏覽器的分享功能,分享給你的好友吧